Prevalence and incidence of cytomegalovirus infection in HIV infected subjects: The French SEROCO cohort;Prevalence et incidence de l'infection par le cytomegalovirus chez les sujets infectes par le VIH-1: Cohorte Francaise SEROCO

Presse Medicale

Volumn 27, Issue 20, 1998, Pages 949-953

  Robain, M ^a,d   Carre N ^a   Salmon Ceron, D ^b   Dussaix, E ^c   Meyer, L ^a  

^a BICÊTRE HOSPITAL   (France)

^b Institut Cochin   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE TRANSMISSION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; RISK ASSESSMENT; SEROCONVERSION; SEXUAL INTERCOURSE; ADULT; AIDS RELATED COMPLEX; CYTOMEGALIC INCLUSION BODY DISEASE; FEMALE; FRANCE; HEALTH SURVEY; HUMAN IMMUNODEFICIENCY VIRUS 1; INCIDENCE; MALE; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SEXUAL BEHAVIOR;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FRANCE; HIV-1; HUMANS; INCIDENCE; MALE; POPULATION SURVEILLANCE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR;

EID: 0032490229     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1989 ; 107:75-80.
2. McKenzie R, Travis WD, Dolan SA et al. The causes of death in patients with human immunodeficiency virus infection : a clinical and pathologic study with emphasis on the role of pulmonary disease. Medicine 1991 ; 70:326-43.
3. Webster A, Cook DG, Emery VC et al. Cytomegalovirus and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet 1989 ; ii:63-6.
4. Rabkin CS, Hatzakis A, Griffiths PD et al. Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. J Infect Dis 1993 ; 168:1260-3.
5. Clarke LM, Duerr A, Feldman J, Sierra, MF, Daidone BJ, Landesman SH. Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1-seronegative and ñseropositive women from urban minority community. J Infect Dis 1996 ; 173:77-82.
6. Prince AM, Szuness W, Millian SJ, David DS. A serologic study of cytomegalovirus infection associated with blood transfusion. N Eng J Med 1971 ; 284:1125-31.
7. Jackson JB, Erice A, Englund JA, Adson JR, Balfour HH. Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1. Transfusion 1988 ; 28:187-9.
8. Bucquet D, Deveau C, Belanger F et al. Cohorte française multicentrique d'adultes infectés par le VIH : description et évolution après 4 ans de suivi. Presse Med 1994 ; 23:1247-51.
9. Rey D, Droit C, Partisiani M, Jacquemin C, Kempf G, Lang JM. Séroprévalence du Cytomegalovirus chez des sujets infectés par le virus de l'immonodéficience humaine. Presse Med 1995 ; 24:1445.
10. Green MS, Cohen D, Slepon R, Robin G, Wiener M. Ethnic and gender differences in the prevalence of anti-cytomegalovirus antibodies among young adults in Israel. Int J Epidemiol 1993 ; 22:720-3.
11. Collier AC, Handsfield HH, Roberts PL et al. Cytomegalovirus infection in women attending a sexually transmitted disease clinic. J Infect Dis 1990 ; 162:46-51.
12. Chandler SH, Holmes KK, Wentworth BB, et al. The epidemiology of cytomegalovirus infection in women attending a sexually transmitted disease clinic. J Infect Dis 1985 ; 152:597-605.
13. Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy. JAMA 1986 ; 7:1904-8.
14. Leach CT, Detels R, Hennessey K, et al. A longitudinal study of cytomegalovirus infection in human immunodeficiency virus type 1-seropositive homosexual men: molecular epidemiology and association with disease progression. J Infect Dis 1994 ; 170:293-8.
15. Salmon-Céron. Prise en charge thérapeutique de la maladie à Cytomégalovirus au cours de l'infection par le VIH ; Du traitement curatif au traitement préemptif : acquis et incertitudes. Presse Med 1998 ; 27:181-8.